Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer
Clinical trial NCT05188781 · COMPLETED
Trial details
- NCT number
- NCT05188781
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-04
- Primary completion
- 2021-08-23
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.